• Strategic Mastery of Cisplatin: Mechanisms, Resistance, and

  2026-05-25

  This article provides a mechanistic deep dive and actionable guidance for translational researchers using Cisplatin (CDDP) in preclinical oncology. Blending evidence from recent resistance studies with practical workflow advice, we outline how to exploit CDDP’s DNA crosslinking and apoptosis-inducing properties, navigate the evolving resistance landscape, and design robust in vitro and in vivo experiments. Drawing on new findings, we spotlight combination therapies and resistance-reversal strategies, while positioning APExBIO’s Cisplatin as a gold-standard tool for cancer research.

• (S)-(+)-Dimethindene maleate: Protocols for M2 Antagonism St

  2026-05-25

  (S)-(+)-Dimethindene maleate enables researchers to selectively interrogate M2 muscarinic acetylcholine receptor signaling and histamine H1 pathways in autonomic, cardiovascular, and respiratory physiology studies. This compound should be used where receptor subtype specificity and robust solubility are required, but is not recommended for non-selective muscarinic or clinical applications.

• Pyridostatin TFA: Advanced Protocols and Insights for G-Quad

  2026-05-24

  Explore the power of Pyridostatin TFA in probing G-quadruplex biology with advanced protocols, expert analysis, and practical insights. This article uniquely bridges mechanistic understanding with optimized assay strategies for telomere biology and anticancer drug development.

• Monomeric Amyloid Beta-Peptide (1-40) Suppresses Microglial

  2026-05-23

  A recent study uncovers that monomeric amyloid-beta, specifically Amyloid Beta-Peptide (1-40), actively inhibits microglial inflammatory responses via an APP/heterotrimeric G protein-dependent pathway. This challenges traditional views of Aβ solely as a pathological agent in Alzheimer’s disease, highlighting its regulatory roles in brain immune homeostasis and developmental neurobiology.

• Catalpol’s Protective Mechanisms in Cardio-Cerebrovascular D

  2026-05-22

  This comprehensive review highlights catalpol’s multi-faceted protective effects in various cardio-cerebrovascular diseases, emphasizing its anti-oxidant, anti-inflammatory, and anti-apoptotic actions. The article provides mechanistic insights, discusses experimental evidence, and evaluates clinical prospects for catalpol as a potential therapeutic candidate.

• Gastrin I (human): Elevating GI Translational Research with

  2026-05-22

  Explore how APExBIO's high-purity Gastrin I (human) is redefining gastric acid secretion pathway research. This in-depth article blends mechanistic insights with strategic guidance, revealing how the peptide’s precise CCK2 receptor activation unlocks new experimental possibilities in human intestinal organoid models for gastrointestinal disorder research and drug development.

• Sitagliptin Phosphate Monohydrate: Unraveling DPP-4 Inhibiti

  2026-05-21

  Explore how Sitagliptin phosphate monohydrate, a potent DPP-4 inhibitor, advances research into incretin hormone modulation and glucose metabolism. This article uniquely integrates mechanistic insights with emerging data on gut stretch and metabolic regulation.

• Tyrothricin Peptide Antibiotic Mixture: Protocols & Innovati

  2026-05-21

  Tyrothricin, a broad-spectrum peptide antibiotic mixture, empowers researchers to dissect and manipulate microbial membrane disruption across bacteria, fungi, and viruses. This article delivers stepwise protocols, troubleshooting guidance, and actionable insights directly informed by recent mechanistic breakthroughs and advanced reference models.

• CCG-1423: Potent RhoA Inhibitor for Cancer and Signal Pathwa

  2026-05-20

  CCG-1423 is a selective small-molecule RhoA inhibitor that blocks MRTF-A/importin α/β1 interaction, suppressing proliferation and invasion in Rho-overexpressing cancer cells. It provides a precision tool for dissecting RhoA/ROCK signaling in both cancer research and tight junction biology. The compound is validated for high-purity, research-only applications and is distributed by APExBIO.

• 3-Deazaadenosine: Unraveling Methylation and Antiviral Pathw

  2026-05-20

  Explore how 3-Deazaadenosine, a potent S-adenosylhomocysteine hydrolase inhibitor, uniquely enables the study of epigenetic regulation and antiviral mechanisms. This article provides a deep dive into its mechanistic action and advanced applications, revealing insights not covered in existing resources.

• Trichostatin A (TSA): Unraveling Epigenetic Control in Cance

  2026-05-19

  Discover how Trichostatin A (TSA) functions as a powerful HDAC inhibitor and epigenetic modulator in cancer research. This in-depth guide explores unique mechanistic insights and advanced applications, setting it apart from other resources.

• Olaparib (AZD2281) in BRCA-Associated Cancer Research Workfl

  2026-05-19

  Olaparib (AZD2281) empowers precision targeting of DNA repair vulnerabilities in BRCA-deficient tumors, offering distinct advantages in DNA damage response assays and radiosensitization studies. This article translates bench findings into actionable protocol enhancements, with troubleshooting insights for maximizing experimental reproducibility and impact.

• Flavopiridol (A3417): Reliable CDK Inhibition for Cancer Res

  2026-05-18

  This article provides an evidence-based, scenario-driven guide to optimizing cell viability and cytotoxicity assays with Flavopiridol (SKU A3417). Drawing on validated data and current literature, it addresses practical challenges in assay reproducibility, protocol tuning, and vendor selection, helping researchers maximize reliability and impact in oncology workflows.

• Hyperthermia Sensitizes BRCA2+ Ovarian Cancer to PARP Inhibi

  2026-05-18

  Mei et al. (2025) reveal that hyperthermia-induced depletion of BRCA2 protein renders BRCA2-proficient ovarian carcinoma cells sensitive to PARP inhibitor therapy. This approach provides a rational, mechanistically grounded strategy to overcome intrinsic resistance in a major subset of ovarian cancers, with potential to expand the clinical utility of DNA damage repair inhibition.

• Diethylmaleate: Precision Redox Control for Advanced Toxicol

  2026-05-17

  Explore how Diethylmaleate delivers targeted glutathione depletion for redox regulation studies and toxicology research. This article reveals new assay design strategies and practical insights distinct from previous coverage.

11444 records 1/763 page Next 12345 下5页 Last page